10 RECOMBINANT SUBUNIT
VACCINE

Clover Biopharmaceuticals is producing a
recombinant subunit vaccine based on the
trimeric S-protein of COVID-19.째째 The oral
recombinant vaccine is being expanded by
Vaxart in tablet formulation, using its
proprietary oral vaccine platform.

11 CLINICAL MANAGEMENT
AND TREATMENT

In severe COVID-19 cases, treatment should be
given to support vital organ functions. People
who think they may have been exposed to
COVID-19 should contact their healthcare
provider immediately. Healthcare personnel
should care for patients in an Airborne Infection
Isolation Room (AIIR). Precautions must be
taken by the healthcare professional, such as
contact precautions and airborne precautions
with eye protection.째째

Individuals with a mild clinical presentation may
not require primary hospitalisation. Close
monitoring is needed for the persons infected
with COVID-19. Elderly patients and those with
prevailing chronic medical conditions such as